Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients
about
Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida speciesBloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot studyInvasive candidiasis in critical care setting, updated recommendations from "Invasive Fungal Infections-Clinical Forum", Iran.Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit settingClinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients.Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based studyEarly diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patientsSoluble glucan is internalized and trafficked to the Golgi apparatus in macrophages via a clathrin-mediated, lipid raft-regulated mechanism.Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review.Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedureAntigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host.Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomeManagement of invasive aspergillosis in patients with COPD: rational use of voriconazole.Leukocyte Dectin-1 expression is differentially regulated in fungal versus polymicrobial sepsis.Invasive fungal infections in patients with cancer in the Intensive Care Unit.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock-Results of a Combined Clinical and Experimental Investigation.Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.1,3-β-d-Glucan contamination of common antimicrobials-authors' response.Application of Culture-Independent Rapid Diagnostic Tests in the Management of Invasive Candidiasis and Cryptococcosis.
P2860
Q31114184-103C6E51-8892-4037-8C70-54283FF8DDCBQ33296907-39077C35-CD35-430E-9D6E-6CD1C349BC5AQ33592749-217D98B1-36C1-44ED-B9BF-64A4AA2D126FQ33711043-DA10A30D-07B4-4A2B-A109-545C9502FF6AQ34260841-1F73AD02-4EAA-4EDA-91CE-91CC1EF45104Q34374081-917F71E0-82A9-4BB4-B39D-F4D444BFBCBEQ34452343-C73E6E0A-18AD-4271-91B6-23A27AB7A58BQ34485719-9A341F98-4B36-45B1-BE50-DE57E068144FQ34487665-29656AD9-9529-46D3-A79B-54A0994FA427Q34505582-FDD3EC10-0C85-433E-8C80-1C8271BF6637Q35100021-D917C830-6843-4046-A320-5EE6B21B9AF0Q35530416-4E6C3254-11E1-4D65-9E57-23E8B192358CQ35908296-5F52E1E8-B9D3-490F-848C-181326B3715EQ36087577-8390B8BC-A14F-498C-B18B-5D0D26A9C697Q36174179-0F659E01-67A3-43E5-B2BB-0F7EF8DA959AQ36437449-03E793AB-00EC-4ADB-8855-FADFC972AD21Q36539727-E69CAC5C-4A1B-44CF-9E40-8E5A0BC6DF8DQ36567799-D1F25CE1-0023-4C6A-938B-F822E39EAC64Q37051568-059BC511-7826-4635-AAE8-4164729C761AQ37287794-539D1516-35F7-4F71-81C8-87FF6EC4B6F8Q37294689-2A2E8A23-586A-4E63-9933-42A4CE6EC040Q37313868-03C098C8-1094-454C-93DE-E099ADDA3208Q37373771-33D4E7B7-B9C5-415B-819F-5F9D06D58E92Q38508539-00B936CD-D563-4736-9CE6-A9FB3C5ABDE1Q40088340-32B4D386-FBB2-4F8D-A441-7C3AD4751D62Q40708990-FB5ED6B4-22FA-4222-BCED-214EAB796451Q44945278-0F57999C-227F-4CD3-81A9-64DD07448BB9Q49425859-0F4C308F-2E53-4FAD-A470-81736F0F9472
P2860
Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Serum glucan levels are not sp ...... n intensive care unit patients
@ast
Serum glucan levels are not sp ...... n intensive care unit patients
@en
type
label
Serum glucan levels are not sp ...... n intensive care unit patients
@ast
Serum glucan levels are not sp ...... n intensive care unit patients
@en
prefLabel
Serum glucan levels are not sp ...... n intensive care unit patients
@ast
Serum glucan levels are not sp ...... n intensive care unit patients
@en
P2093
P2860
P1476
Serum glucan levels are not sp ...... n intensive care unit patients
@en
P2093
Andy Glenn
Angie Larsen
David Williams
John Kalbfleisch
Justin Digby
William Browder
P2860
P304
P356
10.1128/CDLI.10.5.882-885.2003
P577
2003-09-01T00:00:00Z